Cargando…
A Case Study of European Collaboration between the Veterinary and Human Field for the Development of RSV Vaccines
The One Health (OH) approach describes the interconnection between the health of animals, humans, and the environment. The need for collaboration between the veterinary and human fields is increasing due to the rise in several infectious diseases that cross human–animal barriers and need to be addre...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385505/ https://www.ncbi.nlm.nih.gov/pubmed/37514953 http://dx.doi.org/10.3390/vaccines11071137 |
_version_ | 1785081424275046400 |
---|---|
author | Janse, Marga Sesa, Giulia van de Burgwal, Linda |
author_facet | Janse, Marga Sesa, Giulia van de Burgwal, Linda |
author_sort | Janse, Marga |
collection | PubMed |
description | The One Health (OH) approach describes the interconnection between the health of animals, humans, and the environment. The need for collaboration between the veterinary and human fields is increasing due to the rise in several infectious diseases that cross human–animal barriers and need to be addressed jointly. However, such collaboration is not evident in practice, especially for non-zoonotic diseases. A qualitative research approach was used to explore the barriers and enablers influencing collaborative efforts on the development of vaccines for the non-zoonotic RSV virus. It was found that in the European context, most veterinary and human health professionals involved in RSV vaccine development see themselves as belonging to two distinct groups, indicating a lack of a common goal for collaboration. Next to this, the different conceptualizations of the OH approach, and the fact that RSV is not a zoonotic disease, strengthens the opinion that there is no shared need for collaboration. This paper adds insights on how, for a non-zoonotic situation, collaboration between human and veterinary professionals shaped the development of vaccines in both areas; thus, improving public health requires awareness, mutual appreciation, and shared goal setting. |
format | Online Article Text |
id | pubmed-10385505 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103855052023-07-30 A Case Study of European Collaboration between the Veterinary and Human Field for the Development of RSV Vaccines Janse, Marga Sesa, Giulia van de Burgwal, Linda Vaccines (Basel) Article The One Health (OH) approach describes the interconnection between the health of animals, humans, and the environment. The need for collaboration between the veterinary and human fields is increasing due to the rise in several infectious diseases that cross human–animal barriers and need to be addressed jointly. However, such collaboration is not evident in practice, especially for non-zoonotic diseases. A qualitative research approach was used to explore the barriers and enablers influencing collaborative efforts on the development of vaccines for the non-zoonotic RSV virus. It was found that in the European context, most veterinary and human health professionals involved in RSV vaccine development see themselves as belonging to two distinct groups, indicating a lack of a common goal for collaboration. Next to this, the different conceptualizations of the OH approach, and the fact that RSV is not a zoonotic disease, strengthens the opinion that there is no shared need for collaboration. This paper adds insights on how, for a non-zoonotic situation, collaboration between human and veterinary professionals shaped the development of vaccines in both areas; thus, improving public health requires awareness, mutual appreciation, and shared goal setting. MDPI 2023-06-23 /pmc/articles/PMC10385505/ /pubmed/37514953 http://dx.doi.org/10.3390/vaccines11071137 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Janse, Marga Sesa, Giulia van de Burgwal, Linda A Case Study of European Collaboration between the Veterinary and Human Field for the Development of RSV Vaccines |
title | A Case Study of European Collaboration between the Veterinary and Human Field for the Development of RSV Vaccines |
title_full | A Case Study of European Collaboration between the Veterinary and Human Field for the Development of RSV Vaccines |
title_fullStr | A Case Study of European Collaboration between the Veterinary and Human Field for the Development of RSV Vaccines |
title_full_unstemmed | A Case Study of European Collaboration between the Veterinary and Human Field for the Development of RSV Vaccines |
title_short | A Case Study of European Collaboration between the Veterinary and Human Field for the Development of RSV Vaccines |
title_sort | case study of european collaboration between the veterinary and human field for the development of rsv vaccines |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385505/ https://www.ncbi.nlm.nih.gov/pubmed/37514953 http://dx.doi.org/10.3390/vaccines11071137 |
work_keys_str_mv | AT jansemarga acasestudyofeuropeancollaborationbetweentheveterinaryandhumanfieldforthedevelopmentofrsvvaccines AT sesagiulia acasestudyofeuropeancollaborationbetweentheveterinaryandhumanfieldforthedevelopmentofrsvvaccines AT vandeburgwallinda acasestudyofeuropeancollaborationbetweentheveterinaryandhumanfieldforthedevelopmentofrsvvaccines AT jansemarga casestudyofeuropeancollaborationbetweentheveterinaryandhumanfieldforthedevelopmentofrsvvaccines AT sesagiulia casestudyofeuropeancollaborationbetweentheveterinaryandhumanfieldforthedevelopmentofrsvvaccines AT vandeburgwallinda casestudyofeuropeancollaborationbetweentheveterinaryandhumanfieldforthedevelopmentofrsvvaccines |